niacinamide has been researched along with uracil in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (42.11) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 10 (52.63) | 24.3611 |
| 2020's | 1 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Ahn, JH; Hwang, BY; Jang, JY; Jo, YH; Lee, KY; Lee, MK; Liu, Q; Oh, KE; Turk, A; Yang, HH | 1 |
| De Groote, J; Heirwegh, KP; Ramboer, C | 1 |
| Kaempe, B | 1 |
| Dean, JA | 1 |
| Wessman, G; Wessman, GE | 2 |
| Chilcote, DD; Mrochek, JE | 1 |
| Centilli, M; Cross, M; Powers, EL; Simic, M | 1 |
| Scherr, D; Woenckhaus, C | 1 |
| Kerbel, RS; Lee, CR; Man, S; Tang, TC; Xu, P | 1 |
| Chen, PJ; Cheng, AL; Ding, YH; Hsu, C; Hsu, CH; Lin, ZZ; Shao, YY; Shen, YC | 1 |
| Homma, Y; Kaneko, T; Matsushima, H; Morimoto, H; Tsuzaka, Y | 1 |
| Emmenegger, U; Francia, G; Hashimoto, K; Kerbel, RS; Man, S; Tang, TC; Xu, P | 1 |
| Chester, TL; Stalcup, AM | 1 |
| Chen, BB; Cheng, AL; Hsu, C; Hsu, CH; Hsu, CY; Hu, FC; Shen, YC; Shih, TT; Wei, SY; Yu, CW | 1 |
| Cao, JM; Cao, Y; Gong, XJ; Guo, J; Guo, M; Li, D; Lun, YZ; Luo, N; Sun, WP; Tian, YJ; Zhou, SS | 1 |
| Chen, NN; Gu, XY; Li, Z; Lun, YZ; Luo, N; Ma, Q; Tian, YJ; Zhou, SS | 1 |
| Bamba, T; Enya, S; Hamanishi, J; Harata, A; Hojo, H; Izumi, Y; Kashio, S; Kawamoto, H; Kawaoka, S; Konishi, R; Mandai, M; Miura, M; Mizuno, R; Nakao, M; Suzuki, Y; Takahashi, M; Yoda, M | 1 |
2 trial(s) available for niacinamide and uracil
| Article | Year |
|---|---|
Phase II study of combining sorafenib with metronomic tegafur/uracil for advanced hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Carcinoma, Hepatocellular; Diarrhea; Disease-Free Survival; Drug Eruptions; Fatigue; Female; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; Sorafenib; Tegafur; Uracil | 2010 |
Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Biomarkers; Carcinoma, Hepatocellular; Contrast Media; Feasibility Studies; Female; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neovascularization, Pathologic; Niacinamide; Phenylurea Compounds; Predictive Value of Tests; Pyridines; Sorafenib; Tegafur; Uracil; Young Adult | 2011 |
17 other study(ies) available for niacinamide and uracil
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Characterization of tyrosinase inhibitory constituents from the aerial parts of Humulus japonicus using LC-MS/MS coupled online assay.
Topics: Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Humulus; Molecular Structure; Monophenol Monooxygenase; Plant Components, Aerial; Plant Extracts; Structure-Activity Relationship; Tandem Mass Spectrometry | 2018 |
Purine and pyrimidine excretion. I. Chromatographic separation and identification of purine and pyrimidine metabolites in human urine.
Topics: Adenine; Chromatography; Chromatography, Paper; Creatine; Diet; Humans; Hypoxanthines; Liver Diseases; Niacinamide; Nucleosides; Purines; Pyrimidines; Spectrophotometry; Ultraviolet Rays; Uracil; Uridine; Xanthines | 1967 |
Interfering substances in the determination of poisons in autopsy material: nicotinamide, uracil and thymine.
Topics: Humans; Liver; Niacinamide; Spectrophotometry; Thymine; Uracil | 1967 |
Use of nuclear magnetic resonance in determining molecular structure of urinary constituents of low molecular weight.
Topics: Adenine; Aniline Compounds; Creatinine; Guanine; Hypoxanthines; Magnetic Resonance Spectroscopy; Niacinamide; Phenacetin; Uracil; Uridine; Urine | 1968 |
Chemically defined media for Pasteurella multocida and Pasteurella ureae, and a comparison of their thiamine requirements with those of Pasteurella haemolytica.
Topics: Adenine; Amino Acids; Bacteriological Techniques; Chromatography, Paper; Citrates; Culture Media; Densitometry; Glucose; Guanine; Niacinamide; Pantothenic Acid; Pasteurella; Species Specificity; Sucrose; Thiamine; Uracil | 1970 |
Use of automatic digital data acquisition and on-line computer analysis in high-resolution liquid chromatography.
Topics: Autoanalysis; Chromatography; Computers; Cyclic N-Oxides; Hippurates; Hypoxanthines; Mathematics; Methods; Niacinamide; Nicotinic Acids; Orotic Acid; Pyrimidines; Ribonucleosides; Spectrophotometry; Theophylline; Ultraviolet Rays; Uracil; Uric Acid; Xanthines | 1971 |
Requirements for growth of Pasteurella ureae in a chemically defined medium.
Topics: Adenine; Amino Acids; Carbohydrate Metabolism; Culture Media; Guanine; Hypoxanthines; Niacinamide; Pantothenic Acid; Pasteurella; Uracil; Xanthines | 1972 |
Radiation sensitization of bacterial spores and phage T7 by NaBr.
Topics: Adenine; Amino Acids; Bacillus megaterium; Bromine; Butanols; Cell Survival; Coliphages; Cytosine; Deoxyribose; Dose-Response Relationship, Radiation; Ethanol; Flavin Mononucleotide; Imidazoles; Niacinamide; Propylamines; Radiation Effects; Radiation-Sensitizing Agents; Ribose; Spores, Bacterial; Thioglycolates; Uracil | 1974 |
[Studies on complex formation of dehydrogenases with coenzyme analogues].
Topics: Alcohol Oxidoreductases; Benzimidazoles; Binding Sites; Clinical Enzyme Tests; Coenzymes; Energy Transfer; Imides; L-Lactate Dehydrogenase; Niacinamide; Nucleotides; Spectrum Analysis; Uracil; Uracil Nucleotides | 1971 |
Impact of metronomic UFT/cyclophosphamide chemotherapy and antiangiogenic drug assessed in a new preclinical model of locally advanced orthotopic hepatocellular carcinoma.
Topics: Animals; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Carcinoma, Hepatocellular; Cell Line, Tumor; Chorionic Gonadotropin, beta Subunit, Human; Cyclophosphamide; Doxorubicin; Female; Humans; Injections, Subcutaneous; Liver Neoplasms, Experimental; Mice; Mice, Nude; Mice, SCID; Neovascularization, Pathologic; Niacinamide; Phenylurea Compounds; Pyridines; Sorafenib; Survival Rate; Tegafur; Treatment Outcome; Uracil; Xenograft Model Antitumor Assays | 2010 |
[Tegafur-uracil markedly reduced pulmonary metastasis from renal cell carcinoma refractory to sorafenib, interferon and interleukin 2].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Carcinoma, Renal Cell; Drug Resistance, Neoplasm; Humans; Interferons; Interleukin-2; Kidney Neoplasms; Lung Neoplasms; Male; Niacinamide; Phenylurea Compounds; Pyridines; Sorafenib; Tegafur; Tomography, X-Ray Computed; Uracil | 2010 |
Development of a resistance-like phenotype to sorafenib by human hepatocellular carcinoma cells is reversible and can be delayed by metronomic UFT chemotherapy.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Carcinoma, Hepatocellular; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; Humans; Liver Neoplasms, Experimental; Mice; Mice, Nude; Mice, SCID; Niacinamide; Phenylurea Compounds; Pyridines; Sorafenib; Tegafur; Time Factors; Treatment Outcome; Uracil; Xenograft Model Antitumor Assays | 2010 |
Interactions between minimum run time, modifier concentration, and efficiency parameters in a high performance liquid chromatography separation.
Topics: Chromatography, High Pressure Liquid; Methanol; Models, Chemical; Niacinamide; Pressure; Resorcinols; Theobromine; Theophylline; Time Factors; Uracil | 2011 |
Nicotinamide supplementation induces detrimental metabolic and epigenetic changes in developing rats.
Topics: Animals; Betaine; Choline; CpG Islands; Dietary Supplements; DNA; DNA Damage; DNA Methylation; Epigenesis, Genetic; Glucose Intolerance; Homocysteine; Insulin Resistance; Liver; Male; Metabolic Diseases; Niacin; Niacinamide; Oxidative Stress; Promoter Regions, Genetic; Rats; Rats, Sprague-Dawley; Time Factors; Uracil; Vitamin B Complex; Weight Gain | 2013 |
Maternal nicotinamide supplementation causes global DNA hypomethylation, uracil hypo-incorporation and gene expression changes in fetal rats.
Topics: Animals; Betaine; Brain; Dietary Supplements; DNA; DNA Methylation; Down-Regulation; Epigenesis, Genetic; Female; Fetal Death; Fetal Development; Fetus; Gene Expression Regulation, Developmental; Liver; Maternal Nutritional Physiological Phenomena; Neurons; Niacinamide; Placenta; Placentation; Pregnancy; Random Allocation; Rats; Rats, Sprague-Dawley; Uracil | 2014 |
Remote solid cancers rewire hepatic nitrogen metabolism via host nicotinamide-N-methyltransferase.
Topics: Animals; Liver; Mice; Neoplasms; Niacinamide; Nicotinamide N-Methyltransferase; Nitrogen; Uracil; Urea | 2022 |